Latvia - Treatment Success Rate for Patients Treated for Extensively Drug-Resistant Tuberculosis
Since 2014, Latvia Treatment Success Rate for Patients Treated for Extensively Drug-Resistant Tuberculosis decreased by 4.6points year on year. At 61 Percent in 2019, the country was ranked number 59 comparing other countries in Treatment Success Rate for Patients Treated for Extensively Drug-Resistant Tuberculosis. Belgium topped the ranking with 114 Percent in 2019, that is a growth of 2.7points compared to 2018. Thailand recorded the best 5 years average growth at +65.1points per year, while Bangladesh recorded the worst performance at -100points per year.
Loading...
| Date | Percent |
|---|---|
| 2019 | 61.00 |
| 2018 | 60.00 |
| 2017 | 59.00 |
| 2016 | 59.00 |
| 2015 | 50.00 |
Download all data from 2008 to 2019
How does Latvia rank in Treatment Success Rate for Patients Treated for Extensively Drug-Resistant Tuberculosis?
| # | 134 Countries | Percent | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Belgium
|
114.00 % | 2019 | +2.7 % | +2.7 % | View data | |
| 3 |
#3
United States
|
113.00 % | 2019 | +5.6 % | NA | View data | |
| 59 |
#59
Estonia
|
61.00 % | 2019 | +5.2 % | +36.2 % | View data | |
| 59 |
#59
Latvia
|
61.00 % | 2019 | +1.7 % | -4.5 % | View data | |
| 59 |
#59
Poland
|
61.00 % | 2019 | +1.7 % | +25.0 % | View data | |